- Home
- MIRA vs OXBR Comparison
MIRA vs OXBR Comparison
Compare MIRA & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- OXBR
- Stock Information
- Founded
- MIRA 2020
- OXBR 2013
- Country
- MIRA United States
- OXBR Cayman Islands
- Employees
- MIRA N/A
- OXBR N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- OXBR Property-Casualty Insurers
- Sector
- MIRA Health Care
- OXBR Finance
- Exchange
- MIRA Nasdaq
- OXBR Nasdaq
- Market Cap
- MIRA 20.5M
- OXBR 21.3M
- IPO Year
- MIRA 2023
- OXBR 2014
- Fundamental
- Price
- MIRA $0.95
- OXBR $1.92
- Analyst Decision
- MIRA Strong Buy
- OXBR
- Analyst Count
- MIRA 2
- OXBR 0
- Target Price
- MIRA $14.00
- OXBR N/A
- AVG Volume (30 Days)
- MIRA 360.9K
- OXBR 36.6K
- Earning Date
- MIRA 05-12-2025
- OXBR 03-26-2025
- Dividend Yield
- MIRA N/A
- OXBR N/A
- EPS Growth
- MIRA N/A
- OXBR N/A
- EPS
- MIRA N/A
- OXBR N/A
- Revenue
- MIRA N/A
- OXBR $546,000.00
- Revenue This Year
- MIRA N/A
- OXBR N/A
- Revenue Next Year
- MIRA N/A
- OXBR N/A
- P/E Ratio
- MIRA N/A
- OXBR N/A
- Revenue Growth
- MIRA N/A
- OXBR N/A
- 52 Week Low
- MIRA $0.51
- OXBR $0.94
- 52 Week High
- MIRA $5.01
- OXBR $5.81
- Technical
- Relative Strength Index (RSI)
- MIRA 38.16
- OXBR 24.49
- Support Level
- MIRA $1.06
- OXBR $1.84
- Resistance Level
- MIRA $1.29
- OXBR $2.31
- Average True Range (ATR)
- MIRA 0.11
- OXBR 0.24
- MACD
- MIRA -0.02
- OXBR -0.00
- Stochastic Oscillator
- MIRA 4.74
- OXBR 8.12
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.